The laboratory of the future isn’t coming tomorrow—it’s here today. In a building overlooking Boston Harbor, Ginkgo Bioworks has built something that would have seemed like science fiction just a decade ago: a fully autonomous laboratory where AI-powered robots design and execute scientific experiments independently.
This isn’t just automation. This is AI thinking, planning, and discovering on its own.
From Ramen Noodles to Revolutionary Science
Back in 2004, four MIT graduate students made a bold bet that seemed ridiculous at the time. Jason Kelly and his co-founders believed that “programming cells would ultimately be more important than programming computers.” Their vision? Replace the tedious manual labor of laboratory work with robots.
The early days were brutal. Kelly recalls living on ramen noodles, buying equipment on eBay, and facing rejection after rejection from investors. The biotech industry wasn’t ready for their vision of automated laboratories.
Then came the AI boom. In 2014, a blog post from Sam Altman changed everything. Altman wrote about automating biotechnology the same way other technologies were being automated. Kelly reached out immediately: “Man, thanks for this blog post. We’ve been around for five years. It is impossible to raise money.“
The conversation that followed opened the floodgates to Silicon Valley funding.
This transformation mirrors the early days of personal computing. Just as Steve Jobs and Steve Wozniak faced skepticism about putting computers in every home, Kelly’s team endured years of doubt before the world caught up to their vision.
Inside the Robot Laboratory
Today’s Ginkgo Bioworks facility looks nothing like traditional labs. Pipetting robots work in glass-enclosed stations that resemble museum displays. A massive screen displays color-coded schedules showing each robot’s daily experiments. Below it, an oversized track system—like a toy train set—ferries equipment and samples between workstations.
“🔥 As I mentioned before that Physical AI might be the next phase of AI, after the Agentic era. Physical AI = Embodied AI + DePIN + Robotics” — @Karamata2_2
Each robot handles different projects simultaneously:
- Engineering microbes for better fertilizer
- Creating proteins that generate snow and ice
- Pharmaceutical research and development
- Government contract work
- Live cell experimentation
The robots don’t just follow instructions—they execute complex scientific protocols that previously required years of human training to master.
When AI Becomes the Scientist
The real breakthrough came when Ginkgo pushed beyond automation into true AI-driven discovery. In collaboration with OpenAI, co-founder Reshma Shetty challenged ChatGPT to design and create a specific protein from scratch.
Traditionally, this process works like cooking: a human scientist writes the “recipe” (experimental protocol), and robots execute it. But this time, they asked the AI to write the recipe itself.
“We had no idea if it would even be able to make protein,” Shetty admits.
The results were staggering:
- 40% cost reduction compared to human-designed experiments
- 30,000+ experiments completed in just 6 months
- Successful protein synthesis without human intervention
Shetty describes the moment she first saw “a lab notebook entry written by the model” as truly transformative. The AI wasn’t just following orders—it was thinking, hypothesizing, and documenting its work like a human scientist.
This represents a fundamental shift in scientific methodology. Where Shetty once rushed through experimental design to focus on manual execution, she now spends more time on thoughtful planning while robots handle overnight execution.
Historical Parallels: The Democratization of Power
This AI-driven laboratory revolution echoes major technological shifts throughout history. The printing press democratized knowledge by making books accessible beyond monasteries and universities. The personal computer put computational power in every home and office. The internet democratized information sharing globally.
Now, AI-powered laboratories are democratizing scientific research itself.
Jason Kelly predicts a future where “everyday people can ask scientific questions” and get answers through automated experimentation. This could accelerate discovery in ways we’ve never seen—but it also raises serious concerns.
The Dark Side of Democratized Science
Drew Endy, a bioengineering expert at Stanford, warns that this democratization brings unprecedented risks. When AI removes the traditional barriers to scientific experimentation, it opens doors for people with “little to no training in science running experiments with questionable goals.“
Endy and colleagues have documented how AI-powered laboratories could enable:
- Mass production of dangerous viruses
- Development of biological weapons
- Unregulated genetic experimentation
- Biosecurity threats from hostile nations
Historically, biotechnology has been protected by what Endy calls “intellectual gatekeeping“—the years of training required to understand and manipulate biological systems. “Biology has traditionally been hard for people to really gain control over,” he explains. “AI could nudge it a little bit more towards concentration of power.“
This mirrors concerns that arose during the Manhattan Project, when nuclear physics knowledge concentrated dangerous capabilities in the hands of relatively few people. The difference is that AI could distribute these capabilities much more widely.
The Investment Frenzy
The financial markets are taking notice of this laboratory revolution. Multiple tweets highlight growing institutional investment in robotics and AI companies:
“ANTHROPIC JUST PUBLISHED INTERNAL DATA SHOWING AI IS BUILDING ITSELF FASTER THAN EXPECTED. This is not a think piece. This is a lab showing its own numbers. → Claude now writes 80%+ of Anthropic’s codebase → Engineers ship 8x more code per quarter than in 2021-2025” — @predicttime_
Major financial institutions are quietly accumulating positions in AI and robotics companies, recognizing that laboratory automation represents a massive market opportunity.
What Comes Next
We’re witnessing the early stages of a scientific revolution that could accelerate human knowledge in unprecedented ways. AI-powered laboratories promise to:
- Dramatically reduce research costs
- Accelerate drug discovery timelines
- Enable complex experiments impossible for humans
- Democratize access to advanced scientific capabilities
But this transformation demands immediate attention to regulation and safety protocols. As Endy notes, “regulations and policy to mitigate these risks are within human reach, but need to be prioritized well in advance of a biotechnological disaster.“
The question isn’t whether AI will transform laboratory science—it’s whether we’ll manage that transformation responsibly. The future of human discovery may depend on getting that balance right.
Published in Stream · Dispatch #416 · June 5, 2026 · 5 min read.
Reply to paolo@mont3.ch - every email gets a human answer within 24h.